Ethyl-6-bromo-2-pyridinecarboxylate, 99.0%, 100g

3-Phenylpyrazin-2-amine, 95+%, 250mg

3-(N-(4-Chloro-3-methylisoxazol-5-yl)sulfamoyl)thiophene-2-carboxylic acid, 95.0%, 250mg

5-Bromo-2-thiophenecarboxylic acid, 97.0%, 5g

2-Benzyl-2,7-diazaspiro[4.4]nonane-1,3-dione hydrochloride, 95.0%, 500mg

CYCLOHEXANONE, 4-ETHYL-2,6-BIS(3-PYRIDINYLMETHYLENE)-, (2E,6E)-, 98%, 25mg

[(3-methylphenyl)methyl](prop-2-en-1-yl)amine, 95.0%, 10g

N-[2-(4-sulfamoylphenyl)ethyl]acetamide, 95+%, 250mg

2,6-Dichloro-9-cyclopentyl-9H-purine, 98%, 1g

Murexid (CI 56085), ACS, for Complexometry, 25 g, glass packaging

9,9'-Di([1,1'-biphenyl]-4-yl)-9H,9'H-3,3'-bicarbazole>98.0%(HPLC)(T)200mg

(6-(Piperazin-1-yl)pyridin-3-yl)boronic acid, 95.0%, 250mg

3-BROMO-2-(TRIFLUOROMETHYL)BENZYL BROMIDE, 95.0%, 1g